Gene · 389421
Papers2,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of miRNAs as Therapeutic Tools in Sickle Cell Disease. | Medicina (Kaunas) | 2021 | 34684143 | PubTator, text mining | PubMed |
| Insulin Resistance and Cancer: In Search for a Causal Link. | Int J Mol Sci | 2021 | 34681797 | PubTator, text mining | PubMed |
| TGFβ Signaling in the Pancreatic Tumor Microenvironment. | Cancers (Basel) | 2021 | 34680235 | PubTator, text mining | PubMed |
| Identification of Novel Diagnosis Biomarkers for Therapy-Related Neuroendocrine Prostate Cancer. | Pathol Oncol Res | 2021 | 34646089 | PubTator, text mining | PubMed |
| Pancreatic Cancer Small Extracellular Vesicles (Exosomes): A Tale of Short- and Long-Distance Communication. | Cancers (Basel) | 2021 | 34638330 | PubTator, text mining | PubMed |
| LINC00839/miR-144-3p/WTAP (WT1 Associated protein) axis is involved in regulating hepatocellular carcinoma progression. | Bioengineered | 2021 | 34634995 | PubTator, text mining | PubMed |
| A Risk Score Model Incorporating Three m6A RNA Methylation Regulators and a Related Network of miRNAs-m6A Regulators-m6A Target Genes to Predict the Prognosis of Patients With Ovarian Cancer. | Front Cell Dev Biol | 2021 | 34631700 | PubTator, text mining | PubMed |
| LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K/AKT pathway. | Mol Ther Nucleic Acids | 2021 | 34631282 | PubTator, text mining | PubMed |
| hnRNPA2B1 Promotes Colon Cancer Progression via the MAPK Pathway. | Front Genet | 2021 | 34630502 | PubTator, text mining | PubMed |
| Transcriptomic profiling and functional prediction reveal aberrant expression of circular RNAs during osteogenic differentiation in human umbilical cord mesenchymal stromal cells. | Sci Rep | 2021 | 34615899 | PubTator, text mining | PubMed |
| miRNA Profiling of Hungarian Regressive Wilms' Tumor Formalin-Fixed Paraffin-Embedded (FFPE) Samples by Quantitative Real-Time Polymerase Chain Reaction (RT-PCR). | Med Sci Monit | 2021 | 34608109 | PubTator, text mining | PubMed |
| Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis. | Bioengineered | 2021 | 34592879 | PubTator, text mining | PubMed |
| Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer. | Cancer Metastasis Rev | 2021 | 34591242 | PubTator, text mining | PubMed |
| The Role of Non-Coding RNAs in Breast Cancer Drug Resistance. | Front Oncol | 2021 | 34589423 | PubTator, text mining | PubMed |
| Identification and validation of seven RNA binding protein genes as a prognostic signature in oral cavity squamous cell carcinoma. | Bioengineered | 2021 | 34585646 | PubTator, text mining | PubMed |
| lncRNA LOC339524 inhibits the proliferation of bladder cancer cells by targeting the miR-875-5p/COPS7A signaling axis. | Exp Ther Med | 2021 | 34584547 | PubTator, text mining | PubMed |
| Targeting mutant p53 for cancer therapy: direct and indirect strategies. | J Hematol Oncol | 2021 | 34583722 | PubTator, text mining | PubMed |
| Simple and robust methylation test for risk stratification of patients with juvenile myelomonocytic leukemia. | Blood Adv | 2021 | 34580726 | PubTator, text mining | PubMed |
| In Silico Analysis to Explore Lineage-Independent and -Dependent Transcriptional Programs Associated with the Process of Endothelial and Neural Differentiation of Human Induced Pluripotent Stem Cells. | J Clin Med | 2021 | 34575270 | PubTator, text mining | PubMed |
| Modulation of Cellular MicroRNA by HIV-1 in Burkitt Lymphoma Cells-A Pathway to Promoting Oncogenesis. | Genes (Basel) | 2021 | 34573283 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/papers?page=36